Pharmaceutical/Biotech

Nafta by Any Other Name Is Just Fine With Corporate America

October 4, 2018

The sky isn’t falling. That’s the message coming from Corporate America after President Trump reached a deal to revise the North American Free Trade Agreement.

Here’s What’s in the New Nafta

There’s a lot to digest in the new trade agreement that the United States, Mexico and Canada finalized in deadline-beating fashion on Sunday, starting with a name change.

October 2, 2018

The New York Times

There’s a lot to digest in the new trade agreement that the United States, Mexico and Canada, starting with a name change.

Blockchain Hype May Finally Turn Into Reality in Pharmaceuticals

Blockchain believers have delivered little more than hype, mostly failing to get it deployed outside the cryptocurrency space where the technology was developed. But a little-noticed U.S. law could change that, bringing the ledger system to the pharmaceutical business.

September 26, 2018

Bloomberg

Blockchain believers have delivered little more than hype, mostly failing to get it deployed outside the cryptocurrency space where the technology was developed. But a little-noticed U.S. law could change that, bringing the ledger system to the pharmaceutical business.

Companies Stockpile Drugs, Chocolate as They Brace for ‘Hard’ Brexit

Some of the world’s biggest companies are drawing up plans for the unplannable: a March divorce between Britain and the European Union, in which even some basic parameters have yet to be hammered out.

September 20, 2018

The Wall Street Journal

Some of the world’s biggest companies are drawing up plans for the unplannable: a March divorce between Britain and the European Union, in which even some basic parameters have yet to be hammered out.

When Your Prescription Drug Is Tainted With a Chemical 'Used to Make Rocket Fuel'

Wayne Pearl, like millions of people with high blood pressure, takes the widely prescribed generic drug valsartan.

September 12, 2018

Los Angeles Times

Wayne Pearl, like millions of people with high blood pressure, takes the widely prescribed generic drug valsartan.

Hospitals Are Fed Up With Drug Companies, So They're Starting Their Own

A group of major American hospitals, battered by price spikes on old drugs and long-lasting shortages of critical medicines, has launched a not-for-profit generic drug company, Civica Rx, to take some control over the drug supply.

September 7, 2018

Los Angeles Times

A group of major American hospitals, battered by price spikes on old drugs and long-lasting shortages of critical medicines, has launched a not-for-profit generic drug company, Civica Rx, to take some control over the drug supply.

Pfizer's Costly Divorce: Pharma Giant Says Brexit Will Cost It $100M

European companies aren’t alone in their Brexit pain. Pfizer, the U.S.-based drug behemoth, says its costs for dealing with the upcoming split will reach $100m.

September 5, 2018

Fortune

European companies aren’t alone in their Brexit pain. Pfizer, the U.S.-based drug behemoth, says its costs for dealing with the upcoming split will reach $100m.

Supply Chain Delivers Healthcare Value in the Real World

As any supply chain professional knows, sourcing is a critical element of effective procurement.

August 27, 2018

Karen Conway, SCB Contributor

As any supply chain professional knows, sourcing is a critical element of effective procurement.

Five Emerging Tech Trends That Blur the Lines Between Human and Machine

The 35 must-watch technologies represented on the Gartner Inc. Hype Cycle for Emerging Technologies, 2018 revealed five distinct emerging technology trends that will blur the lines between humans and machines.

August 21, 2018

Gartner

The 35 must-watch technologies represented on the Gartner Inc. Hype Cycle for Emerging Technologies, 2018 revealed five distinct emerging technology trends that will blur the lines between humans and machines.

Big Tech's New Alliance Is Good News for the Health of A.I.

Some of the biggest tech giants Monday agreed to build health care products that use a common set of standards in order to make it easier to share medical data across hospitals. What’s more, these are open standards and specifications aimed at encouraging “frictionless data exchange.”

August 14, 2018

Fortune

Some of the biggest tech giants Monday agreed to build health care products that use a common set of standards in order to make it easier to share medical data across hospitals. What’s more, these are open standards and specifications aimed at encouraging “frictionless data exchange.”